Literature DB >> 18692287

Risk of cardiopulmonary arrest after acute respiratory compromise in hospitalized patients.

Henry E Wang1, Benjamin S Abella, Clifton W Callaway.   

Abstract

BACKGROUND: Hospitalized patients with serious medical conditions such as shock, aspiration, pulmonary edema or stroke may develop acute respiratory compromise (ARC) requiring rescue treatment by medical emergency teams. We determined the characteristics and clinical course of hospitalized patients experiencing ARC as well as their risk of developing subsequent CPA.
METHODS: We examined data from the National Registry of Cardiopulmonary Resuscitation (NRCPR). We identified patients experiencing ARC, defined as medical crisis requiring emergency assisted ventilation and triggering hospital-wide or unit-based emergency response. We excluded those found initially in CPA. We identified the proportion of patients subsequently progressing to CPA, the elapsed time from ARC recognition to CPA, the clinical factors associated with developing CPA, and subsequent survival to hospital discharge.
RESULTS: Of 4358 ARC events, CPA occurred in 726 (16.7%; 95% CI: 15.6, 17.8%). One-fourth occurred in general inpatient units. Median time from ARC recognition to CPA was 7 min (IQR: 3, 12 min); CPA occurred within 10 min in 65.3% of these cases. Factors associated with CPA included pulmonary embolism, hypotension or hypoperfusion, or failed invasive airway efforts. Survival to discharge was lower for CPA patients (14.3%) than non-CPA patients (58.4%) (OR 0.12; 95% CI: 0.10, 0.15).
CONCLUSIONS: Approximately one in six patients experiencing initial ARC deteriorates to CPA. Most CPA occur within 10 min of ARC recognition. Improved ARC recognition, hospital emergency team response and airway management may potentially enhance care and outcomes for these critically ill patients.

Entities:  

Mesh:

Year:  2008        PMID: 18692287     DOI: 10.1016/j.resuscitation.2008.06.025

Source DB:  PubMed          Journal:  Resuscitation        ISSN: 0300-9572            Impact factor:   5.262


  6 in total

1.  Predicting in-hospital mortality for initial survivors of acute respiratory compromise (ARC) events: Development and validation of the ARC Score.

Authors:  Ari Moskowitz; Lars W Andersen; Mathias Karlsson; Anne V Grossestreuer; Maureen Chase; Michael N Cocchi; Katherine Berg; Michael W Donnino
Journal:  Resuscitation       Date:  2017-03-04       Impact factor: 5.262

2.  Failure of Invasive Airway Placement on the First Attempt Is Associated With Progression to Cardiac Arrest in Pediatric Acute Respiratory Compromise.

Authors:  Hannah R Stinson; Vijay Srinivasan; Alexis A Topjian; Robert M Sutton; Vinay M Nadkarni; Robert A Berg; Tia T Raymond
Journal:  Pediatr Crit Care Med       Date:  2018-01       Impact factor: 3.624

3.  Pediatric In-Hospital Acute Respiratory Compromise: A Report From the American Heart Association's Get With the Guidelines-Resuscitation Registry.

Authors:  Lars W Andersen; Mikael Vognsen; Alexis Topjian; Linda Brown; Robert A Berg; Vinay M Nadkarni; Hans Kirkegaard; Michael W Donnino
Journal:  Pediatr Crit Care Med       Date:  2017-09       Impact factor: 3.624

4.  Acute Respiratory Compromise in the Emergency Department: A Description and Analysis of 3571 Events from the Get With the Guidelines-Resuscitation® Registry.

Authors:  Carl Mathias Karlsson; Michael W Donnino; Hans Kirkegaard; Michael N Cocchi; Maureen Chase; Lars W Andersen
Journal:  J Emerg Med       Date:  2017-01-17       Impact factor: 1.484

5.  Factors associated with the occurrence of cardiac arrest after emergency tracheal intubation in the emergency department.

Authors:  Won Young Kim; Myoung Kwan Kwak; Byuk Sung Ko; Jae Chol Yoon; Chang Hwan Sohn; Kyoung Soo Lim; Lars W Andersen; Michael W Donnino
Journal:  PLoS One       Date:  2014-11-17       Impact factor: 3.240

6.  Acoustic respiration rate and pulse oximetry-derived respiration rate: a clinical comparison study.

Authors:  Michal E Eisenberg; Dalia Givony; Raz Levin
Journal:  J Clin Monit Comput       Date:  2018-11-26       Impact factor: 2.502

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.